← Eichor
Study identifier: NCT05729607 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Vertical Soft Tissue Augmentation With CTG vs ADM

Condition: Implant Complication  ·  Sponsor: Harvard Medical School (HMS and HSDM)

PhaseNA
Planned participants28
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersYes

About this study

The study aims at comparing two different approaches for vertical soft tissue augmentation at implant sites exhibiting soft tissue dehiscences: autogenous connective tissue graft vs acellular dermal matrix + enamel matrix derivative

This description comes directly from the study's public registry record.

Talk to the study team

Lorenzo Tavelli, DDS, MS  ·  734-604-4364  ·  lorenzo_tavelli@hsdm.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Harvard School of Dental MedicineBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05729607